RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Clinical trials for RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) explained in plain language.
Never miss a new study
Get alerted when new RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) trials appear
Sign up with your email to follow new studies for RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Real-World data shows promise for epcoritamab in Tough-to-Treat lymphoma
Disease control OngoingThis study tracks how well the drug epcoritamab works for 150 adults with diffuse large B-cell lymphoma that has come back or not responded to at least two prior treatments. Researchers are measuring tumor shrinkage and side effects in everyday medical practice, not just in stric…
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Sponsor: Andrés José Maria Ferreri • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Can stem cell dose boost recovery in tough lymphoma?
Disease control OngoingThis study looks at whether the number of stem cells given during a transplant affects recovery for people with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). About 59 adults who have already tried one chemotherapy and are eligible for a stem cell transplant will r…
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC